Baseline characteristics of subjects in the lipoprotein and coronary atherosclerosis study (LCAS) with fluvastatin
Authors:
- M.STewart WestMWM.STewart West
- Christie BallantyneCBChristie Ballantyne
- John FarmerJFJohn Farmer
- Antonio M. GottoAGAntonio M. Gotto
- 1 May 1994
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 73 (14) , D42-D49
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Clinical Pharmacokinetics and Practical Applications of SimvastatinClinical Pharmacokinetics, 1993
- Design features of a controlled clinical trial to assess the effect of an HMG CoA reductase inhibitor on the progression of coronary artery diseaseControlled Clinical Trials, 1993
- Women in the POSCH Trial Effects of Aggressive Cholesterol Modification in Women With Coronary Heart DiseaseAnnals of Surgery, 1992
- Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)The Lancet, 1992
- Rhabdomyolyse causée par la simvastatine chez un transplanté cardiaque sous ciclosporineLa Revue de Médecine Interne, 1992
- Beneficial Effects of Colestipol-Niacin on Coronary AtherosclerosisJAMA, 1990
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with HypercholesterolemiaNew England Journal of Medicine, 1990
- Can lifestyle changes reverse coronary heart disease?The Lancet, 1990
- Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.Circulation, 1985